Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03912194 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 11, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Mar 1, 2026 to Jul 1, 2026 Completion date: Jun 24, 2026 to Jul 1, 2026 · Collaborators expanded, about 6 wordsv8 Show 2 more changesShow less
    • Completion date: Jun 24, 2026 to Jul 1, 2026
    • Collaborators expanded, about 6 words

    See this version in full on ClinicalTrials.gov ↗

  2. Site contact updatedv7
  3. Primary completion date: Mar 1, 2024 to Mar 1, 2026 Completion date: Jun 24, 2024 to Jun 24, 2026v6 Show 1 more changeShow less
    • Completion date: Jun 24, 2024 to Jun 24, 2026
  4. 3 versions Re-verified since Sep 13, 2021, no change to tracked fieldsv3-v5
  5. Trial status: Not Yet Recruiting to Recruiting Site details revisedv2 Show 1 more changeShow less
    • Site details revised
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Smoking remains the single most preventable cause of morbidity and mortality in the United States, accounting for approximately half a million deaths every year. The current study will investigate the efficacy and mechanisms of change of a novel smoking cessation intervention. The current study will thus provide essential information regarding a treatment that has the potential to enhance the efficacy of existing smoking cessation interventions, thereby having a beneficial impact on the public health of the United States.
Trial Details
NCT Number NCT03912194
Lead Sponsor University of Alabama at Birmingham
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Tobacco Dependence
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov